olivlawolivlaw

olivLaw · US equity research

Lakeland Industries, Inc. LAKE

Orthopedic, Prosthetic & Surgical Appliances & Supplies · SIC 3842 · Vertical: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)

8.93USD−0.11% · 1 dayClose 04 Nov 2026

Lakeland Industries, Inc., operating as Lakeland Fire + Safety, makes protective equipment for firefighters, industry and first responders, and most of its sales are made outside the US. The company is now trying to build a fire services platform while industrial markets and tariff pressures remain sensitive, with net sales of $192.6 million in fiscal 2026.

At the close of 04 Nov 2026, Lakeland Industries, Inc. (LAKE) stock was 8.93 USD (−0.11% on the day), with market capitalisation 88.7 m USD, dividend yield 3.47%, beta 1.13, 52-week range 7.58–16.69 USD. Latest reported quarter (Q2 2027): revenue of 50.1 m USD (−4.5% YoY), net income of -4.9 m USD (−743.5% YoY), diluted EPS -0.50 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
88.7 m USD
shares as of 04 Sept 2026
P/E (TTM)
unavailable
Diluted EPS TTM -2.73 · TTM to 31 Jul 2026
E/P (TTM)
-30.61%
TTM to 31 Jul 2026
Dividend yield
3.47%
Beta (2y)
1.13
Volatility (1y) 78%
52-week range
7.5816.69

Price history

Loading chart…

Technical reading

RSI (14)
38.8
weak (30–45)
Bollinger (20, 2)
8.58 – 10.03
in the lower half of the band · %B 0.24 · band width 15.6%
SMA 50 / 200
10.22 / 10.12
mixed trend
MACD (12, 26, 9)
-0.39 / -0.39
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month−24.1%−1.1%−23.0 pp—
3 months−28.2%−0.5%−27.8 pp—
6 months−7.3%+4.4%−11.7 pp—
Year to date+1.0%+12.3%−11.3 pp—
1 year−44.5%+13.5%−58.1 pp+2.0%
3 years−39.1%+76.4%−115.5 pp−0.2%
5 years−57.5%+63.7%−121.2 pp—
Max drawdown (1y)
−54.6%
05 Nov 2025 → 27 Mar 2026
Max drawdown (5y)
−71.4%
15 Jan 2025 → 27 Mar 2026
Compound annual growth (5y)
−15.7%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q2 2027 · 31 Jul 2026

Revenue
50.1 m USD
−4.5% YoY
Net income
-4.9 m USD
−743.5% YoY
Diluted EPS
-0.50
−725.0% YoY
net / operating
-9.8% / -6.7%

Quarterly margins

Quarterly statements · USD

Fiscal yearQ3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27Q2 '27
Revenue45.8 m46.6 m46.7 m52.5 m47.6 m45.8 m47.4 m50.1 m
Cost of revenue27.2 m27.9 m31.1 m33.7 m33.5 m31.1 m32.5 m31.6 m
Gross profit18.6 m18.7 m15.6 m18.8 m14.1 m14.7 m14.9 m18.5 m
Operating income807.0 k-10.7 m-4.6 m-4.0 m-1.6 m-5.2 m2.3 m-3.3 m
Depreciation & amortisation1.2 m ≈-411.0 k1.1 m1.3 m ≈1.2 m ≈-815.0 k1.3 m1.4 m ≈
Interest expense490.0 k618.0 k583.0 k445.0 k502.0 k617.0 k614.0 k525.0 k
Pre-tax income233.0 k-18.8 m-5.1 m-4.4 m-2.3 m-5.9 m1.7 m-3.7 m
Income tax147.0 k-397.0 k-1.2 m-5.2 m13.7 m356.0 k1.3 m1.2 m
Net income86.0 k-18.4 m-3.9 m766.0 k-16.0 m-6.2 m369.0 k-4.9 m
Diluted EPS0.01-2.71 ≈-0.410.08-1.64-0.63 ≈0.04-0.50
Operating cash flow-8.4 m ≈-3.4 m-4.8 m-4.8 m ≈-7.9 m ≈1.8 m5.8 m-404.0 k ≈
Capex643.0 k ≈55.0 k1.2 m921.0 k ≈-1.3 m ≈-113.0 k1.4 m43.0 k ≈
Dividends paid222.0 k223.0 k285.0 k286.0 k287.0 k294.0 k02.5 m

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Fiscal years

Fiscal year201920202021202220232024⚠ 20252026
Revenue99.0 m107.8 m159.0 m118.4 m6.0 m6.3 m167.2 m192.6 m
Revenue YoY+3.2%+8.9%+47.5%−25.5%−94.9%+5.0%—+15.2%
Net income1.5 m3.3 m35.3 m11.4 m1.9 m5.4 m-18.1 m-25.3 m
Net income YoY+231.6%+124.9%+976.8%−67.8%−83.5%+189.6%—unavailable
Diluted EPS0.180.414.341.410.240.72-2.43-2.63
Diluted EPS YoY+200.0%+127.8%+958.5%−67.5%−83.0%+200.0%—unavailable
net %1.5%3.0%22.2%9.6%31.2%86.1%-10.8%-13.1%
Free cash flow-1.3 m2.6 m39.0 m12.0 m-7.4 m8.8 m-17.4 m-16.4 m

The series breaks before 2025: earlier years come from the original reports of the issuer of that time, later years from a subsequent filing that restated the perimeter (a separation, discontinued operations). The year-on-year change across the break is not shown.

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2026 · 31 Jan 2026

Cash
12.5 m USD
Financial debt
32.3 m USD
Net debt
19.8 m USD
Equity
129.1 m USD
Total assets
209.9 m USD
Debt / equity
0.25x
Current ratio
3.53x
ROE
-18.4%
ROA
-12.0%
FCF margin
-8.5%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2024
6.3 m
2025
167.2 m
2026
192.6 m

SEC (XBRL)· 16 Apr 2026verified

Cost of revenue
2024
73.5 m
2025
98.5 m
2026
129.3 m

SEC (XBRL)· 16 Apr 2026verified

Gross profit
2024
51.2 m
2025
68.7 m
2026
63.3 m

SEC (XBRL)· 16 Apr 2026verified

Research & development
2024
—
2025
—
2026
—

SEC (XBRL)· 16 Apr 2021verified

Operating income
2024
6.0 m
2025
-9.3 m
2026
-15.5 m

SEC (XBRL)· 16 Apr 2026verified

Depreciation & amortisation
2024
1.9 m
2025
2.6 m
2026
2.8 m

SEC (XBRL)· 16 Apr 2026verified

EBITDA
2024
7.9 m ≈
2025
-6.7 m ≈
2026
-12.7 m ≈

SEC (XBRL)· 16 Apr 2026derived

Interest expense
2024
52.0 k
2025
1.7 m
2026
2.1 m

SEC (XBRL)· 16 Apr 2026verified

Pre-tax income
2024
9.4 m
2025
-18.4 m
2026
-17.7 m

SEC (XBRL)· 16 Apr 2026verified

Income tax
2024
3.9 m
2025
-281.0 k
2026
7.6 m

SEC (XBRL)· 16 Apr 2026verified

Net income
2024
5.4 m
2025
-18.1 m
2026
-25.3 m

SEC (XBRL)· 16 Apr 2026verified

Diluted EPS
2024
0.72
2025
-2.43
2026
-2.63

SEC (XBRL)· 16 Apr 2026verified

Weighted average diluted shares
2024
—
2025
7.4 m
2026
9.6 m

SEC (XBRL)· 16 Apr 2026verified

Balance sheet · USD

Cash
2024
28.4 m
2025
17.5 m
2026
12.5 m

SEC (XBRL)· 16 Apr 2026verified

Receivables
2024
21.8 m
2025
27.6 m
2026
32.0 m

SEC (XBRL)· 16 Apr 2026verified

Inventories
2024
56.1 m
2025
82.7 m
2026
82.5 m

SEC (XBRL)· 16 Apr 2026verified

Current assets
2024
113.8 m
2025
136.5 m
2026
134.2 m

SEC (XBRL)· 16 Apr 2026verified

Property, plant & equipment, net
2024
11.9 m
2025
13.9 m
2026
11.6 m

SEC (XBRL)· 16 Apr 2026verified

Goodwill
2024
15.2 m
2025
16.2 m
2026
15.3 m

SEC (XBRL)· 16 Apr 2026verified

Intangibles (excl. goodwill)
2024
7.9 m
2025
25.5 m
2026
31.7 m

SEC (XBRL)· 16 Apr 2026verified

Total assets
2024
171.5 m
2025
212.5 m
2026
209.9 m

SEC (XBRL)· 16 Apr 2026verified

Accounts payable
2024
9.1 m
2025
15.7 m
2026
15.6 m

SEC (XBRL)· 16 Apr 2026verified

Short-term debt
2024
0
2025
939.0 k
2026
1.9 m

SEC (XBRL)· 16 Apr 2026verified

Long-term debt
2024
—
2025
16.4 m
2026
30.4 m

SEC (XBRL)· 16 Apr 2026verified

Current liabilities
2024
21.1 m
2025
34.9 m
2026
38.0 m

SEC (XBRL)· 16 Apr 2026verified

Total liabilities
2024
46.4 m
2025
65.9 m
2026
80.8 m

SEC (XBRL)· 16 Apr 2026verified

Equity
2024
125.1 m †
2025
146.6 m †
2026
129.1 m †

SEC (XBRL)· 16 Apr 2026verified

Shares outstanding at year end
2024
7.4 m
2025
—
2026
—

SEC (XBRL)· 11 Apr 2024verified

Cash flow · USD

Operating cash flow
2024
10.9 m
2025
-15.9 m
2026
-15.8 m

SEC (XBRL)· 16 Apr 2026verified

Capex
2024
2.1 m
2025
1.5 m
2026
671.0 k

SEC (XBRL)· 16 Apr 2026verified

Free cash flow
2024
8.8 m ≈
2025
-17.4 m ≈
2026
-16.4 m ≈

SEC (XBRL)· 16 Apr 2026derived

Investing cash flow
2024
-5.1 m
2025
-47.7 m
2026
-1.2 m

SEC (XBRL)· 16 Apr 2026verified

Financing cash flow
2024
-3.5 m
2025
56.6 m
2026
12.5 m

SEC (XBRL)· 16 Apr 2026verified

Dividends paid
2024
908.0 k
2025
887.0 k
2026
1.2 m

SEC (XBRL)· 16 Apr 2026verified

Computed indicators

Growth

Revenue growth (YoY)
15.2%
computed by olivLawFY 2026
Revenue CAGR 3Y
217.8%
computed by olivLawFY 2023 → FY 2026
Revenue CAGR 5Y
3.9%
computed by olivLawFY 2021 → FY 2026
EBIT growth (YoY)
unavailable
the base of the ratio is not positive
Net income growth (YoY)
unavailable
the base of the ratio is not positive
Net income CAGR 3Y
unavailable
the base of the ratio is not positive
Net income CAGR 5Y
unavailable
the base of the ratio is not positive
EPS growth (YoY)
unavailable
the base of the ratio is not positive
EPS CAGR 3Y
unavailable
the base of the ratio is not positive
EPS CAGR 5Y
unavailable
the base of the ratio is not positive
FCF growth (YoY)
unavailable
the base of the ratio is not positive

Profitability

Gross margin
32.6%
computed by olivLawTTM to 31 Jul 2026
EBITDA margin
-2.5%
computed by olivLawTTM to 31 Jul 2026
EBIT margin
-4.1%
computed by olivLawTTM to 31 Jul 2026
Net margin
-14.0%
computed by olivLawTTM to 31 Jul 2026
FCF margin
-0.4%
computed by olivLawTTM to 31 Jul 2026

Returns

ROE
-19.6%
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
ROA
-12.3%
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
ROIC
-4.9%
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
ROCE
-4.9%
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
the base of the ratio is not positive

Balance sheet

Net debt
10.8 m USD
computed by olivLawbalance sheet at 31 Jul 2026
Net debt / EBITDA
unavailable
insufficient data
Debt / equity
0.2x
computed by olivLawbalance sheet at 31 Jul 2026
Interest coverage
-3.5x
computed by olivLawTTM to 31 Jul 2026

Liquidity

Current ratio
3.0x
computed by olivLawbalance sheet at 31 Jul 2026
Quick ratio
1.3x
computed by olivLawbalance sheet at 31 Jul 2026
Cash ratio
0.4x
computed by olivLawbalance sheet at 31 Jul 2026

Cash

Operating cash flow
-693.0 k USD
computed by olivLawTTM to 31 Jul 2026
Capital expenditure
25.0 k USD
computed by olivLawTTM to 31 Jul 2026
Free cash flow
-718.0 k USD
computed by olivLawTTM to 31 Jul 2026
FCF conversion
unavailable
insufficient data
Cash conversion
unavailable
insufficient data

Efficiency

Days sales outstanding
60 days
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
Days inventory outstanding
234 days
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
Days payables outstanding
51 days
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
Cash conversion cycle
243 days
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026

Market and valuation

Market capitalisation
88.7 m USD
computed by olivLawbalance sheet at 31 Jul 2026
Enterprise value
99.5 m USD
computed by olivLawbalance sheet at 31 Jul 2026
Market cap / net income TTM
unavailable
insufficient data
P/E (TTM)
unavailable
insufficient data
Earnings yield
-30.6%
computed by olivLawTTM to 31 Jul 2026
P/B
0.7x
computed by olivLawbalance sheet at 31 Jul 2026
P/S
0.5x
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
EV/EBITDA
unavailable
insufficient data
EV/EBIT
unavailable
insufficient data
EV/Sales
0.5x
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
P/FCF
unavailable
the base of the ratio is not positive
FCF yield
-0.8%
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
Dividend yield
3.5%
computed by olivLawTTM to 31 Jul 2026
Shareholder yield (distributions)
3.5%
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 50.0% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

8.93 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 88.7 m USD

Key indicators

Market capitalisation
88.7 m USD
computed by olivLawbalance sheet at 31 Jul 2026
P/E (TTM)
unavailable
insufficient data
P/B
0.7x
computed by olivLawbalance sheet at 31 Jul 2026
EV/EBITDA
unavailable
insufficient data
ROE
-19.6%
computed by olivLawTTM to 31 Jul 2026 · balance sheet at 31 Jul 2026
Net margin
-14.0%
computed by olivLawTTM to 31 Jul 2026
Revenue growth (YoY)
15.2%
computed by olivLawFY 2026
Dividend yield
3.5%
computed by olivLawTTM to 31 Jul 2026

Coverage and freshness

34/37 reporting lines present
Latest full fiscal year: 2026
Latest reported period: 31 Jul 2026
Latest balance sheet date: 31 Jul 2026
Share count (cover of the latest filing), as of: 04 Sept 2026
Source: SEC (XBRL)published 09 Sept 2026
verified 2366derived 149

Score by group

50% · Insufficient data

Estimated value range

Low
1.16
USD per share
Mid
1.70
USD per share
High
2.63
USD per share
Price: 8.93 USD
The price is above the range
Potential to the central value: -80.9% (value / price − 1)
Margin of safety: -424.3% (1 − price / value)
Agreement between methods: single method · 1 methods used · 1 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 1.16 – 2.63 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)1.16 – 2.63 (Mid 1.70)
    WACC 8.3% · starting FCFF 1.2 m USD · terminal value share of EV 77%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: no growth between −30% and +40% justifies the price
  • Peers: EV/EBITDAunavailable · the base of the ratio is not positive
  • Peers: P/Eunavailable · the base of the ratio is not positive
  • Dividend discount (DDM)unavailable · input data missing
Multiple comparisons use the SIC vertical: Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: score weight coverage: 50.0% of at least 60%

FactorValueScoreWeight used
ROIC · Quality-4.9%27 (vs peers)21%
Net margin · Quality-14.0%50 (vs peers)13%
FCF conversion · Qualityunavailableunavailable—
Revenue CAGR 3Y · Growth217.8%100 (on a fixed band)17%
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet-3.5x0 (on a fixed band)13%
Current ratio · Balance sheet3.0x100 (on a fixed band)8%
P/E (TTM) · Valuationunavailableunavailable—
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation-0.8%0 (on a fixed band)17%
Shareholder yield (distributions) · Returns3.5%50 (on a fixed band)13%
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet40/100 · 2/3 factors with a value
  • Growth· partial100/100 · 1/2 factors with a value
  • Quality36/100 · 2/3 factors with a value
  • Returns· partial50/100 · 1/2 factors with a value
  • Valuation· partial0/100 · 1/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

LAKELAND INDUSTRIES, INC. (LAKE). Latest full fiscal year: 2026; data up to 2026-07-31.

Figures computed from the financial statements: revenue 192.6 m USD in 2026; YoY growth 15.2%; net margin -14.0%; ROE -19.6%.

The estimated value range is 1.16–2.63 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 1.70 USD, the price of 8.93 USD leaves a potential of -80.9% (value / price − 1) and a margin of safety of -424.3% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (score weight coverage: 50.0% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • Revenue CAGR 3Y: 217.8%
  • Current ratio: 3.0x

What contradicts it

  • ROIC: -4.9%
  • Interest coverage: -3.5x
  • FCF yield: -0.8%
  • The price is above the estimated value range

Not assessed (insufficient data or a ratio without meaning): FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Payout ratio (FCF).

Versus the vertical median

Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) · same industry (4-digit SIC) · compared with 23 companies

Multiples and returns vs the median

P/E
—
vertical median 31.9x
EV/EBITDA
—
vertical median 16.0x
P/S
0.5x
vertical median 3.7x
below median (−87.4%)
P/B
0.7x
vertical median 4.8x
below median (−85.1%)
ROE
-19.6%
vertical median -30.3%
above median
Net margin
-14.0%
vertical median -11.4%
below median
EBIT margin
-4.1%
vertical median -2.3%
below median
Revenue YoY
15.2%
vertical median 6.7%
above median (+128.3%)
Net debt/EBITDA
—
vertical median 2.9x
Dividend yield
3.5%
vertical median 1.0%
above median (+241.8%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ISRGIntuitive Surgical, Inc.167.1 bn58.318.0%25.5%+20.5%−16% / +55%
EWEdwards Lifesciences Corporation57.1 bn56.29.7%15.3%+11.5%+15% / +47%
SNNSmith & Nephew plc28.5 bn45.311.8%10.1%+6.1%−2% / +25%
STESTERIS plc24.2 bn30.011.4%13.3%+8.7%−7% / +23%
ZBHZimmer Biomet Holdings, Inc.20.8 bn27.96.0%9.0%+7.2%+13% / −5%
ALGNAlign Technology, Inc.11.6 bn24.011.9%11.8%+0.9%+12% / −23%
MSAMsa Safety Inc6.8 bn22.822.1%15.0%+3.7%+10% / +2%
ESTAEstablishment Labs Holdings Inc.2.0 bn—-175.3%-15.8%+27.1%−3% / +161%
ENOVEnovis Corp1.4 bn—-54.3%-48.0%+6.7%−19% / −51%
CDRECadre Holdings, Inc.1.3 bn33.811.6%5.6%+7.5%−28% / −4%
AVRAnteris Technologies Global Corp.596.4 m—-75.1%-4,619.3%−29.2%+49% / unavailable
COCHEnvoy Medical, Inc.549.6 m——-11,304.8%+7.1%+749% / +216%
ZJYLJin Medical International Ltd.483.7 m309.04.1%5.8%−12.0%−39% / −87%
SMTISanara Medtech Inc.297.0 m—-147.7%-29.2%+19.0%+55% / −0%
INGNInogen, Inc.191.6 m—-13.1%-6.9%+3.9%+2% / +24%
LAKELakeland Industries, Inc.88.7 m—-19.6%-14.0%+15.2%−45% / −39%
NTRBNutriband Inc.73.9 m—-100.7%-430.4%−4.8%+23% / +140%
APTAlpha Pro Tech, Ltd.58.6 m14.16.6%6.8%+2.3%+25% / +17%
CLGNCollPlant Biotechnologies Ltd54.2 m—-117.6%-484.6%+360.4%−81% / −92%
MYOMyomo, Inc.51.5 m—-123.8%-33.5%+25.7%+46% / −58%
MLSSMilestone Scientific Inc.29.2 m—-121.7%-44.0%+4.0%+6% / −61%
LFWDLifeward Ltd.17.2 m—-225.6%-141.3%−14.1%−13% / −90%
CUPRCuprina Holdings (Cayman) Limited14.1 m—-1,115.0%-9,366.7%+9.2%−64% / unavailable
BBLGBone Biologics Corporation1.2 m—-47.5%—0.0%−77% / −98%

1- and 3-year price returns: for LAKE from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
3 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
5 years
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
insufficient data
Total return unavailable · Per year unavailable
What moves the 3-year price the most

    AI analysis

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    In brief

    Lakeland Industries, Inc., operating as Lakeland Fire + Safety, makes protective equipment for firefighters, industry and first responders, and most of its sales are made outside the US. The company is now trying to build a fire services platform while industrial markets and tariff pressures remain sensitive, with net sales of $192.6 million in fiscal 2026 1.

    SWOT

    Strengths

    • The company owns manufacturing capacity in several countries, giving it control over quality and the supply chain 1.
    • The Fire range is head-to-toe and supported by UL certifications and contracts in several countries 3.
    • The company has a broad international customer base and a distribution network across dozens of countries 1.

    Weaknesses

    • Margins and net results have been under pressure, and in the second quarter the company reported a net loss after a goodwill impairment 3.
    • Currency exposure and conversion costs weighed on quarterly results, and the company is now evaluating hedging instruments 3.
    • Inventory and cash flow management remains a priority, and debt and liquidity are being monitored closely 3.

    Opportunities

    • Growth in fire services and tender-based contracts could bring recurring revenue and better absorption of fixed costs 3.
    • If NFPA standards and demand for new equipment continue, Fire sales could remain a growth driver 3.
    • Expanding US production capacity could reduce reliance on imports and the tariffs attached to them 1.

    Threats

    • Tariffs and shifts in trade policy could raise costs and reduce demand in key markets 1.
    • Geopolitical conflicts in Ukraine and the Middle East could affect shipping, supply and demand 1.
    • Larger competitors with greater resources could pressure prices and market share 1.

    Risks

    • Tariff and trade policy exposurehigh

      Production in China, Vietnam and Mexico could be hit by new tariffs, and uncertain refunds do not guarantee cost recovery 1.

    • Currency riskmedium

      Currency losses weighed on the second quarter, and the company has not yet settled on a full hedging strategy 3.

    • Goodwill impairmentmedium

      The impairment tied to LHD Germany shows some acquisitions can underperform, and further charges could follow if results do not improve 3.

    • Supply chain and logisticsmedium

      Transport delays, raw material shortages and higher freight costs could disrupt production and deliveries 1.

    • Internal controlmedium

      The company has identified a material weakness in internal control over financial reporting, which could affect investor confidence 2.

    Investment thesis

    What would need to be true (bull case)

    • If tender wins in Europe and other regions turn into deliveries, Fire revenue could keep growing.
    • Better gross margins and lower inventory could lead to stronger cash generation.
    • If firefighter services expand, they could add recurring revenue and reduce dependence on one-off sales.

    What would break the thesis

    • If tariffs stay in place or rise, production costs could remain high and squeeze margins.
    • The second-quarter net loss and impairment show that some acquisitions have not delivered the results expected.
    • If the industrial segment does not recover, total sales could stay under pressure.

    What to watch

    • Progress of Fire tenders and contracts, including the UK frameworkQ3 FY27
    • Gross margin and adjusted EBITDA excluding FXQ3 FY27
    • Inventory and debt levels, including use of the revolving credit facility2027
    • Repositioned results of LHD Germany and other Fire acquisitionsnext 10-K

    Products, market & competition

    AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

    The business

    Lakeland designs, manufactures and sells protective equipment: firefighter apparel, high-end chemical suits, limited-use and durable woven garments, and services for cleaning, inspection and repair of firefighting gear 1. The company operates nine manufacturing locations in eight countries and sells through distributors, with sales representatives in 23 countries, and more than half of fiscal 2026 sales came from outside the US 1. Between 2024 and 2026 it acquired Jolly, LHD, Veridian, Arizona PPE and California PPE as part of a roll-up strategy in firefighting 1.

    In the second quarter of fiscal 2027, ended July 31, 2026, net sales were $50.1 million and the Fire division accounted for 52% of the total 3. The company reported a gross margin of 37.0%, but also a non-cash goodwill impairment of about $3.2 million tied to LHD Germany 3. Management says the priority is improving existing businesses rather than rapid expansion through acquisitions 3.

    In March 2026 the company sold its high performance FR/AR apparel and high visibility clothing lines, which changes the structure of its industrial portfolio 1. As a NASDAQ-listed company, Lakeland reports quarterly and annually, and its debt and liquidity disclosures show a partly drawn revolving credit facility 3.

    Segments

    Fire

    The Fire division covers firefighter turnout gear, helmets, hoods and boots, plus maintenance services for firefighters, and generated $26.1 million in the second quarter of fiscal 2027 13. Fire services revenue rose 78% year over year to about $3.5 million 3.

    Industrial

    The industrial division covers chemical suits and limited-use and woven garments for petrochemical, automotive, laboratory and other sectors, and generated $24.0 million in the second quarter of fiscal 2027 13. Excluding the divested lines, industrial revenue rose about 3% 3.

    Market context

    The company argues that long-term global demand for protective equipment is rising, because purchases are often mandated by standards and regulations 1. The market is nonetheless highly fragmented, with small single-product competitors and a few large multinationals 1. Sales are made in more than 50 countries, and Europe, Latin America and Asia showed growth or fluctuation in the quarter analysed 13.

    Technical standards change frequently, and compliance with NFPA and CE standards is becoming a competitive barrier 1. Government tender activity in Europe and other regions brought large contracts in the quarter, although their timing remains uncertain 3.

    Trends

    • Tariffs and international trademixed

      US tariffs on imports from China, Vietnam, Mexico and India raise costs and could reduce competitiveness, and the rules change quickly 1. If tariff refunds materialise, they could support margins, as seen in the second quarter 3.

    • NFPA standards and equipment renewaltailwind

      The move to updated NFPA standards has boosted demand for helmets, hoods and turnout gear, which can support Fire sales 3.

    • Freight and raw material costsheadwind

      Higher freight costs, raw material inflation and supply chain disruptions have affected production efficiency and margins 1.

    • Consolidation in firefighter servicestailwind

      Acquisitions of decontamination and repair services for firefighting gear could create recurring revenue if integration succeeds 13.

    Competitive position

    Lakeland describes its market as highly competitive, with competitors varying by region and product, and some having substantially greater resources 12. The company competes on product quality, availability, brand recognition and customer service, and on its own manufacturing, which it argues gives a more resilient supply chain than rivals using contractors 1.

    Direct comparison is difficult, because competitors are often small specialists or diversified multinationals, and the sources give no full list of market shares 1.

    • Small specialist PPE makers

      Regional competitors selling a single category of equipment, cited generically in the annual report.

    • Large multinational safety product suppliers

      Large competitors offering many types of PPE with greater financial resources, according to the company.

    • Contract manufacturers

      Producers using outside contractors, which Lakeland compares with its own factories.

    • Local industrial equipment distributors

      Distribution networks competing for the same industrial and utility customers.

    News & filings

    In the press

    SEC filings

    • Quarterly report09 Sept 2026
    • Current report09 Sept 2026
      Results of operations · Regulation FD disclosure · Financial statements and exhibits
    • Current report18 Jun 2026
      Departure or appointment of officers · Shareholder vote · Financial statements and exhibits
    • Quarterly report09 Jun 2026
    • Current report09 Jun 2026
      Results of operations · Regulation FD disclosure · Financial statements and exhibits
    • Proxy statement07 May 2026
    • Annual report16 Apr 2026
    • Current report16 Apr 2026
      Results of operations · Regulation FD disclosure · Financial statements and exhibits
    • Current report30 Mar 2026
      Material agreement · Regulation FD disclosure · Financial statements and exhibits
    • Current report23 Feb 2026
      Departure or appointment of officers · Regulation FD disclosure · Financial statements and exhibits

    Sources

    1. [1] Form 10-K, fiscal year ended 2026-01-31 · SEC / Lakeland Industries, Inc. · 16 Apr 2026
    2. [2] Form 10-Q, quarter ended 2026-07-31 · SEC / Lakeland Industries, Inc. · 09 Sept 2026
    3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Lakeland Industries, Inc. · 09 Sept 2026

    Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.